Sertralin Hexal tablet

Sertralin Hexal is a widely used pharmaceutical product containing sertraline, an antidepressant belonging to the Selective Serotonin Reuptake Inhibitors (SSRIs) group. The brand Hexal was founded in Germany and grew to become one of the country's leading generic drug providers.

Today, Hexal is an integral part of Sandoz, which was successfully spun off from the Swiss multinational pharmaceutical giant Novartis in late 2023. While Hexal maintains deep roots in the German market, the manufacturing of its products, including sertraline, occurs across a global network of production facilities to ensure supply chain stability. As of 2024 and beyond, Sandoz operates as an independent, publicly traded company specializing in generic and biosimilar medicines, with its global headquarters located in Basel, Switzerland.